Adam Berger, MD, FACS

Adam Berger, MD, FACS

Contact Dr. Berger

1100 Walnut Street
MOB, Suite 500
Philadelphia, PA 19107

(215) 955-1622
(215) 923-8222 fax

Most Recent Peer-reviewed Publications

  1. Monitoring neoadjuvant chemotherapy for breast cancer by using three-dimensional subharmonic aided pressure estimation and imaging with US contrast agents: Preliminary experience
  2. Surgical Apgar score (SAS) predicts perioperative morbidity, mortality, and length of stay in patients undergoing esophagectomy at a high-volume center
  3. Comparative Quantitative Lymph Node Assessment in Localized Esophageal Cancer Patients After R0 Resection With and Without Neoadjuvant Chemoradiation Therapy
  4. Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum
  5. VAPC-1 Targeted64Cu-TP3805 kit preparation and its evaluation
  6. A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown
  7. Completion dissection or observation for sentinel-node metastasis in melanoma
  8. Do intraoperative pyloric interventions predict the need for postoperative endoscopic interventions after minimally invasive esophagectomy?
  9. Patient Symptoms Are the Most Frequent Indicators of Recurrence in Patients with American Joint Committee on Cancer Stage II Melanoma
  10. Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes
  11. Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients
  12. Long-term functional outcomes of laparoscopic resection for gastric gastrointestinal stromal tumors
  13. Melanoma
  14. Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction
  15. NRG oncology radiation therapy oncology group 0822: A phase 2 study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer
  16. Contrast-enhanced sonography for detection of secondary lymph nodes in a melanoma tumor animal model
  17. Vorinostat as a radiosensitizer for brain metastasis: A phase i clinical trial
  18. Outcomes in patients with mucosal melanomas
  19. A better prognosis for Merkel cell carcinoma of unknown primary origin
  20. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma